Exane Derivatives’s Bridgetown Holdings Limited Class A Ordinary Shares BTWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-40,000
Closed -$619K 971
2020
Q4
$619K Buy
+40,000
New +$538K 0.18% 118

Other funds holding BTWN

Exane Derivatives's BTWN Position: Q1 2021 in Review

Exane Derivatives sold out of Bridgetown Holdings Limited Class A Ordinary Shares (BTWN) in Q1 2021, closing a stake of 40,000 shares — an estimated $619K sold.

Exane Derivatives first reported a position in BTWN in Q4 2020 and held it in 1 quarter. The position peaked at $619K in Q4 2020. 67 funds tracked by Wall St. Rank hold BTWN as of Q1 2021.

  • Exane Derivatives reported no remaining Bridgetown Holdings Limited Class A Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Exane Derivatives sold 40,000 Bridgetown Holdings Limited Class A Ordinary Shares shares in Q1 2021, an estimated $619K.
  • Exane Derivatives first reported a position in Bridgetown Holdings Limited Class A Ordinary Shares in Q4 2020 and held it in 1 quarter.
  • Exane Derivatives's Bridgetown Holdings Limited Class A Ordinary Shares position peaked at $619K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Bridgetown Holdings Limited Class A Ordinary Shares as of Q1 2021.

Based on Exane Derivatives's 13F filing for Q1 2021, filed 30 Apr 2021.